Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00481507 · ClinicalTrials.gov registry record · NA

Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)

A NA study of Respiratory Tract Infections, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT00481507: Completed NA study of Respiratory Tract Infections, sponsored by Georgetown University.

NCT00481507 is a NA study of Respiratory Tract Infections that has completed, run by Georgetown University. The registered enrollment target is 125 participants, below the 2,766-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00481507, a NA study of Respiratory Tract Infections, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effectiveness of commercially available kefir on preventing antibiotic-associated diarrhea compared to placebo in children ages 1-5.

Primary Outcome

The primary outcome was the incidence of participants receiving antibiotics with diarrhea during the 14-day follow-up period, as determined by parental report.

Interventions

  • OTHER Placebo
  • OTHER Kefir

Study Locations (1)

District of Columbia

  • Georgetown University Deptartment of Family Medicine - Washington D.C.

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2007-07
Est. Completion 2008-04
Phase NA
Georgetown University

227 total trials

What the finished NCT00481507 record still lists

NCT00481507 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 2,766-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00481507 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00481507 about?

NCT00481507 is a clinical study titled "Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)". The purpose of this study is to determine the effectiveness of commercially available kefir on preventing antibiotic-associated diarrhea compared to placebo in children ages 1-5.

What is the current status of trial NCT00481507?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2007-07. Estimated completion is 2008-04.

What conditions does trial NCT00481507 study?

This clinical trial studies the following conditions: Respiratory Tract Infections.

What interventions are being tested in trial NCT00481507?

The interventions under investigation include: Placebo (OTHER), Kefir (OTHER).

Who is sponsoring clinical trial NCT00481507?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00481507 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Tract Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00481507's enrollment target sits among peer trials

125 11th of 15 higher than 5 of 15 other Respiratory Tract Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00481507, the US trial registry maintained by the National Library of Medicine. NCT00481507 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.